Homeeditorial

editorial

Relay Therapeutics to Present Clinical Data on RLY-4008 at ESMO Congress

Relay Therapeutics to Present Clinical Data on RLY-4008 at ESMO Congress

August 19, 2022

FDA Accepts Krystal Biotech’s Biologics License Application for Dystrophic Epidermolysis Bullosa

FDA Accepts Krystal Biotech’s Biologics License Application for Dystrophic Epidermolysis Bullosa

August 19, 2022

Is Palantir a Good Investment?

Is Palantir a Good Investment?

August 19, 2022

Bill.com Shares Jumped 19% After Reporting Fiscal Q4 Results and Solid Guidance

Bill.com Shares Jumped 19% After Reporting Fiscal Q4 Results and Solid Guidance

August 19, 2022

SpringWorks Therapeutics Announces Late-Breaking Oral Presentation of Phase 3 DeFi Data at the European Society for Medical Oncology (ESMO) Congress 2022

SpringWorks Therapeutics Announces Late-Breaking Oral Presentation of Phase 3 DeFi Data at the European Society for Medical Oncology (ESMO) Congress 2022

August 19, 2022

Bit Digital Selects Nine Blocks Capital Management for Treasury Management Allocation

Bit Digital Selects Nine Blocks Capital Management for Treasury Management Allocation

August 19, 2022

Digivault now supports BNB Chain

Digivault now supports BNB Chain

August 19, 2022

Peppercomm Named Public Relations Agency of Record for AgriFORCE

Peppercomm Named Public Relations Agency of Record for AgriFORCE

August 19, 2022

Independent Proxy Advisor Egan-Jones Joins ISS in Recommending Shareholders Vote “AGAINST” All Aviat Director Nominees

Independent Proxy Advisor Egan-Jones Joins ISS in Recommending Shareholders Vote “AGAINST” All Aviat Director Nominees

August 19, 2022

FormFactor Announces Participation at Upcoming Conferences

FormFactor Announces Participation at Upcoming Conferences

August 19, 2022

« 1 … 1,211 1,212 1,213 1,214 1,215 … 1,422 »